Fast-Paced workouts may shield aging brains from dementia
NCT ID NCT07444554
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a 12-week high-velocity resistance training program can improve brain blood flow and thinking skills in adults aged 60 to 79 who are at higher risk for Alzheimer's disease. Participants will be randomly assigned to either the exercise program or their usual routine. Researchers will measure changes in executive function, processing speed, and how well the brain regulates blood flow during mental and physical tasks. The goal is to see if this type of exercise can help protect brain health and guide future prevention strategies.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- High-velocity resistance training (a type of exercise focusing on fast, controlled movements with moderate weights)
- What this could lead to
- If it works, this could point toward a simple, drug-free way to help protect thinking skills and brain health in older adults at risk for dementia.
- What could go wrong
- This is a small, early-stage study (60 people) testing a behavioral intervention, not a drug. Results may not apply to everyone, and the exercise program requires commitment and supervision.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
May 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 to 79 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 60 to 79 years * Able to walk on a treadmill at a comfortable, self-selected pace for at least 30 minutes with short breaks * Has at least one vascular risk factor (such as high blood pressure or high cholesterol) * Has a first-degree family history of dementia or self-reported concerns about memory or thinking * Fluent in English * Willing and able to provide written informed consent * Cleared to participate in supervised resistance training based on physical activity screening and, if required, physician clearance Exclusion Criteria: * Diagnosis of Alzheimer disease, other dementia, stroke, Parkinson disease, multiple sclerosis, or another major neurological disorder * Unstable cardiovascular disease (such as recent heart attack, unstable chest pain, or uncontrolled abnormal heart rhythm) * Uncontrolled high blood pressure * Major psychiatric illness that would interfere with participation * Medical condition that makes moderate-to-high intensity resistance training unsafe * Current participation in structured high-intensity resistance training * Any medical condition that, in the opinion of the study investigator, would increase risk during participation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for At risk for ad-dementia, with subjective cognitive decline are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.